Abstract:Studies in the area of human brain development are critical as research on neurological and psychiatric disorders has advanced, revealing the origins of pathophysiology to be in the earliest developmental stages. Only with a more precise understanding of the genes and environments that influence the brain in these early stages can we address questions about the pathology, diagnosis, prevention and treatment of neuropsychiatric disorders of developmental origin, like autism, schizophrenia, and Tourette syndrome. A new approach for studying early developmental events is the use of induced pluripotent stem cells (iPSCs). These are cells with wide potential, similar to that of embryonic stem cells, derived from mature somatic cells. We review the protocols used to create iPSCs, including the most efficient and reliable reprogramming strategies available to date for generating iPSCs. In addition, we discuss how this new tool can be applied to neuropsychiatric research. The use of iPSCs can advance our understanding of how genes and gene products are dynamically involved in the formation of unique features of the human brain, and how aberrant genetic variation may interfere with its typical formation. The iPSC technology, if properly applied, can also address basic questions about neural differentiation such as how stem cells can be guided into general and specific neurodevelopmental pathways. Current work in neuropsychiatry with iPSCs derived from patients has focused on disorders with specific genetics deficits and those with less-defined origins; it has revealed previously unknown aspects of pathology and potential pharmacological interventions. These exciting advances based on the use of iPSCs hold promise for improving early diagnosis and, possibly, treatment of psychiatric disorders. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.

The power of human stem cell-based systems in the study of neurodevelopmental disorders

Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges

Stem Cell–Based Organoid Models of Neurodevelopmental Disorders

Deciphering the physiopathology of neurodevelopmental disorders using brain organoids

Brain Organoids as Model Systems for Genetic Neurodevelopmental Disorders

Stem Cell Technology for (Epi)genetic Brain Disorders

In vivo models to study neurogenesis and associated neurodevelopmental disorders-Microcephaly and autism spectrum disorder

Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: from 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism

Modeling neurological disorders by human induced pluripotent stem cells

Stem cell-based region-specific brain organoids: Novel models to understand neurodevelopmental defects

A quantitative framework to evaluate modeling of cortical development by neural stem cells.

Understanding neural development and diseases using CRISPR screens in human pluripotent stem cell-derived cultures

Assembloid CRISPR screens reveal impact of disease genes in human neurodevelopment

The Effects of Environmental Adversities on Human Neocortical Neurogenesis Modeled in Brain Organoids

[The contribution of cerebral organoids to the understanding and treatment of rare genetic diseases with neurodevelopmental disorders]

Brain organoids: A new tool for modelling of neurodevelopmental disorders

Building on a Solid Foundation: Adding Relevance and Reproducibility to Neurological Modeling Using Human Pluripotent Stem Cells

An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders

Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders